Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study

Scarmeas, N., Daskalaki, A., Kalligerou, F., Ntanasi, E., Mamalaki, E., Gargalionis, A. N., Patas, K., Chatzipanagiotou, S., Yannakoulia, M., & Constantinides, V. C. (2022). Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study. Medicina, 58(9), 1179. https://doi.org/10.3390/medicina58091179
Authors:
Nikolaos Scarmeas
Argyro Daskalaki
Faidra Kalligerou
Eva Ntanasi
Eirini Mamalaki
Antonios N. Gargalionis
Kostas Patas
Stylianos Chatzipanagiotou
Mary Yannakoulia
Vasilios C. Constantinides
Affiliated Authors:
Nikolaos Scarmeas
Columbia Affiliation:
Author Keywords:
alzheimer's disease
biomarker
csf biomarker
neurodegeneration
albion study
alzheimer’s disease
elink
Publication Type:
Article
Unique ID:
10.3390/medicina58091179
PMID:
36143858
DOI:
10.3390/medicina58091179
Journal:
Medicina
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record

Record Created: